These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 5539965)

  • 1. [Spironolactone (Aldactone) as a stage in the treatment of hypertension].
    Storm-Mathisen H
    Tidsskr Nor Laegeforen; 1971 Jan; 91(3):224-5. PubMed ID: 5539965
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antialdosterones and arterial hypertension. Apropos of 32 hypertensive cases treated with an aldactone-derivative-thiazide combination].
    Delahaye JP; Lieux JM; Gonin A
    Lyon Med; 1966 Sep; 216(38):477-97. PubMed ID: 5981275
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical study of the efficacy of oral potassium canrenoate and spironolactone in essential arterial hypertension].
    Tosti-Croce C; Mantellini R; Fanti P; Sciarra F
    Minerva Med; 1983 Apr; 74(14-15):791-7. PubMed ID: 6339999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Spironolactone and propranolol in combination therapy of arterial hypertension].
    Di Veroli C; Compagno S; Iugoli AR
    Clin Ter; 1982 Nov; 103(3):283-7. PubMed ID: 7151382
    [No Abstract]   [Full Text] [Related]  

  • 5. A spironolactone-hydroflumethiazide combination in hypertension.
    Practitioner; 1971 Mar; 206(233):412-5. PubMed ID: 4929196
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bullous pemphigoid induced by spironolactone].
    Modeste AB; Cordel N; Courville P; Gilbert D; Lauret P; Joly P
    Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):56-8. PubMed ID: 11937932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amiloride 10 mg is less effective than spironolactone 25 mg in patients with hypertension resistant to a multidrug regime including an angiotensin-blocking agent.
    Lane DA; Beevers DG
    J Hypertens; 2007 Dec; 25(12):2515-6. PubMed ID: 17984678
    [No Abstract]   [Full Text] [Related]  

  • 8. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
    Mahmud A; Mahgoub M; Hall M; Feely J
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of aldactone in hypertension and nephritis].
    Shul'ga IuD; Kondratskaia LV
    Vrach Delo; 1971 Mar; 3():33-6. PubMed ID: 5578012
    [No Abstract]   [Full Text] [Related]  

  • 10. [Variations of renin activity in hypertensive patients under aldactone therapy].
    Popov NG; Kiprov D; Astrug A; Dotschev D
    Med Welt; 1971 Jul; 22(29):1207-9. PubMed ID: 5566156
    [No Abstract]   [Full Text] [Related]  

  • 11. [Multi-centric study for the evaluation of the antihypertensive efficacy of hydrochlorothiazide and spironolactone association: comparison between 2 dosages schemes].
    Fariello R; Porcellati C; Innocenti PF; Corea L; Roncati G
    Clin Ter; 1983 Jun; 105(6):477-85. PubMed ID: 6617110
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of thiazide and thiazide-potassium sparing diuretics on fibrinolytic system parameters.
    Kaşifoğlu T; Yalçin AU
    Anadolu Kardiyol Derg; 2006 Jun; 6(2):143-7. PubMed ID: 16766279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative evaluation of aldactide and methyldopa in the management of benign essential hypertension.
    Nair KG; Jairam HN; Lal HM; Phaterpekar SJ
    J Assoc Physicians India; 1980; 28(1-2):7-13. PubMed ID: 7216969
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of arterial hypertension in elderly patients].
    Halawa B
    Wiad Lek; 1981 Aug; 34(16):1357-62. PubMed ID: 7041432
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of add-on aldosterone receptor blocker in uncontrolled hypertension.
    Sharabi Y; Adler E; Shamis A; Nussinovitch N; Markovitz A; Grossman E
    Am J Hypertens; 2006 Jul; 19(7):750-5. PubMed ID: 16814132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term low-dose spironolactone therapy is safe in oligoanuric hemodialysis patients.
    Matsumoto Y; Kageyama S; Yakushigawa T; Arihara K; Sugiyama T; Mori Y; Sugiyama H; Ohmura H; Shio N
    Cardiology; 2009; 114(1):32-8. PubMed ID: 19342857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldosterone antagonist therapy in resistant hypertension.
    Zannad F
    J Hypertens; 2007 Apr; 25(4):747-50. PubMed ID: 17351364
    [No Abstract]   [Full Text] [Related]  

  • 18. The bioavailability of spironolactone hydrochlorothiazide combination preparation.
    Rameis H; Hitzenberger G; Horwatitsch H
    Int J Clin Pharmacol Ther Toxicol; 1982 Jul; 20(7):327-33. PubMed ID: 7107086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of spironolactone and indapamide in the treatment of low-renin arterial hypertension].
    Naudzhunas A; Bagdonas G; Yankauskene L; Kazanavichus G
    Ter Arkh; 2006; 78(2):61-4. PubMed ID: 16613101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long term experiences with a solid spironolactone-furosemide combination in heart insufficiency and hypertension].
    Bachour G
    Med Klin Prax; 1982 May; 77(10):54-8. PubMed ID: 6808328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.